Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/1999
11/04/1999CA2326819A1 Delivery of therapeutic proteins via implantation of genetically modified cells in the omentum
11/04/1999CA2326755A1 G-csf receptor agonist antibodies and screening method therefor
11/04/1999CA2326695A1 Enzymatic nucleic acid treatment of diseases or conditions related to hepatitis c virus infection
11/04/1999CA2326601A1 Ese genes and proteins
11/04/1999CA2326378A1 Efficient ex vivo expansion of cd4+ and cd8+ t-cells from hiv infected subjects
11/04/1999CA2326377A1 Internalizing erbb2 antibodies
11/04/1999CA2326376A1 Polyepitope carrier protein
11/04/1999CA2326375A1 Basb006 polynucleotide(s) and polypeptides from neisseria meningitis
11/04/1999CA2326233A1 Delayed rectifier potassium channel subunit
11/04/1999CA2326114A1 Periadventitial delivery device
11/04/1999CA2326001A1 Fizz proteins
11/04/1999CA2324251A1 Certain heteroaryl substituted thiol inhibitors of endothelin-converting enzyme
11/04/1999CA2323691A1 Certain thiol inhibitors of endothelin-converting enzyme
11/04/1999CA2323235A1 Adenoviral vectors for treating disease
11/03/1999EP0953641A2 Polynucleotide molecules encoding neospora proteins
11/03/1999EP0953639A1 FAPalpha-specific antibody with improved producibility
11/03/1999EP0953638A1 Human vanilloid receptor-like cation channel
11/03/1999EP0953637A2 Acetylcholine receptor
11/03/1999EP0953630A1 Transesterification products of corn oil and glycerol and their use in pharmaceutical compositions
11/03/1999EP0953576A1 Active hedgehog protein conjugate, process for its production and use
11/03/1999EP0953575A1 Active hedgehog protein conjugate, process for its production and use
11/03/1999EP0953573A2 Pentapeptide with specific conformation, its production and use
11/03/1999EP0953572A2 Peptides binding to bone marrow stromal cell antigen
11/03/1999EP0953362A2 Methods and apparatus for the delivery of solid drug compositions
11/03/1999EP0953357A1 Nephrotropic drugs
11/03/1999EP0953354A1 Hematopoietic stem cell proliferating agents
11/03/1999EP0953351A2 Medicaments containing, as the main ingredient, allogenic activated-CD4+ cells and method for producing the same
11/03/1999EP0953153A1 Novel method of diagnosing and treating gliomas
11/03/1999EP0953051A1 Use of chemokine antagonist molecules for their antiviral activity, particularly against an hiv type retrovirus
11/03/1999EP0953050A1 Novel means for the diagnosis, prevention and treatment of contamination or infections by viruses with mucous tropism
11/03/1999EP0953049A2 Novel human metallothionein
11/03/1999EP0953048A1 Compounds for modulating cell negative regulations and biological applications thereof
11/03/1999EP0953042A1 Methods and reagents for regulating telomere length and telomerase activity
11/03/1999EP0952987A2 Antibodies against epitopes, exposed on surfaces of cancer cells outside desmosomes, of desmosomal cadherines
11/03/1999EP0952986A1 Antimicrobially active polypeptides
11/03/1999EP0952983A2 Unique dendritic cell-associated c-type lectins, dectin-1 and dectin-2; compositions and uses thereof
11/03/1999EP0952982A2 Novel hepatitis b inhibitors
11/03/1999EP0952855A1 Use of hyaluronan in gene therapy
11/03/1999EP0952846A1 Prolactin as a vaccine adjuvant
11/03/1999EP0952845A1 Treatment of mammalian myocardium with morphogen locally, or with morphogenically-treated myogenic precursor cells
11/03/1999EP0952844A1 USE OF PROTEIN S-100b IN MEDICINES AND MEDICINES CONTAINING THE PROTEIN S-100b
11/03/1999EP0952843A2 Pharmaceutical formulations for sustained drug delivery
11/03/1999EP0952842A2 A method of treating cancer
11/03/1999EP0952827A1 Amino acid compositions and use thereof in immunosuppression
11/03/1999EP0952823A1 Stabilized pharmaceutical compositions and process for the preparation thereof
11/03/1999EP0952821A1 Processes for spray drying aqueous suspensions of hydrophobic drugs with hydrophilic excipients and compositions prepared by such processes
11/03/1999EP0952772A1 Compositions and methods of use of mononuclear phagocytes to promote axonal regeneration
11/03/1999EP0853484A4 Novel mu opioid receptor ligands: agonists and antagonists
11/03/1999EP0773992A4 Transgenically produced antithrombin iii
11/03/1999EP0763055B1 Perfluoroalkyl ketone inhibitors of elastase and processes for making the same
11/03/1999EP0754058B1 Wound healing
11/03/1999EP0737073A4 Novel peptides for heparin and low molecular weight heparin anticoagulation reversal
11/03/1999EP0658096B1 Stabilized chewable antimicrobial animal foodstuff
11/03/1999EP0401303B2 Novel human tissue plasminogen activator variants and processes
11/03/1999EP0371998B2 Modular assembly of antibody genes, antibodies prepared thereby and use
11/03/1999CN1234078A Compositions and method for treating viral infections
11/03/1999CN1234073A Circularly permuted erythropoietin receptor agonists
11/03/1999CN1234072A Anti-ErbB2 antibodies
11/03/1999CN1234071A Keratinocyte grouth factor -2(KGF-2 or fibroblast growth factor-12, FGF-12)
11/03/1999CN1234039A 3-mercaptoacetylamino-1,5-subsd. 2-oxo-azepon derivatives useful as inhibitor of metrix metalloproteinase
11/03/1999CN1234038A C-end modified (N-subsd.)-2-indyldipeptide used for ICE/ced-3 family cysteine protein enzyme inhibitor
11/03/1999CN1233963A Ophthalmic compositions of neurotrophic factor, remedies for optic nerve function disorders and method for treating same
11/03/1999CN1233959A Stabilized pharmaceutical compositions, with quinupristine and dalfopristine base and their prepn.
11/03/1999CN1233952A Nasal administration of desmopressin
11/03/1999CN1233616A Active hedgehog protein conjugate, process for its prodn. and use
11/03/1999CN1233503A Total hormone replacement therapy
11/02/1999US5977458 Corn inbred lines for dairy cattle feed
11/02/1999US5977341 Antisense modulation of inhibitor-kappa B kinase-beta expression
11/02/1999US5977340 Antisense oligonucleotides for inhibiting helicobacter pylori activity
11/02/1999US5977338 Polynucleotides which hybridize with naturally occurring sequences encoding human interferon-inducible protein (hifi) and the polynucleotides which identify and encode hifi.
11/02/1999US5977337 The nucleic acid molecule may be used in the diagnosis of infection.
11/02/1999US5977336 High molecular weight surface proteins of non-typeable haemophilus
11/02/1999US5977323 Purifying inflammatory cytokine/chemokine by immunoaffinity chromatography; complexing chemokine to anti-gro antibodies bound to matrix, eluting chemokine
11/02/1999US5977322 Human antibody that specifically binds to c-erbb-2 protein product of her2/neu oncogene; for diagnosis of cancer/tumors which over express this gene; for immunotoxins and other antitumor/anticarcinogenic agents; less immunogenic
11/02/1999US5977320 Antibody to novel human phosphorylase kinase gamma subunit
11/02/1999US5977318 The ctla4 receptor as a ligand for the b7 antigen.
11/02/1999US5977315 Murine anti-idiotype antibody 3H1
11/02/1999US5977314 Catalytic antibodies against cocaine
11/02/1999US5977313 Nondegraded active fibrinogen or fragments bound to insoluble carrier; anticarcinogenic/antitumor/antimetastasis agents to remove circulating metastatic tumour cells, or suppress deposition in vessels; treatment of thrombocytopenia
11/02/1999US5977311 53BP2 complexes
11/02/1999US5977310 Polyethylene glycol modified hepatocyte growth factor; prolonged clearance in vivo with same physiological activity; for reduced dosage with reduced side effects; viricides; anticarcinogenic agents; treatment of liver/kidney disorders
11/02/1999US5977309 Growth inhibitory polypeptide; for diagnosis of cancer; anticarcinogenic/antimetastasis agents against breast cancer and leukemia
11/02/1999US5977308 Platelet-activating factor acetylhydrolase
11/02/1999US5977307 Transferrin receptor specific ligand-neuropharmaceutical agent fusion proteins
11/02/1999US5977306 Therapeutic compositions to protect animals from diseases caused by parasitic helminths.
11/02/1999US5977303 Mammalian cell surface antigens
11/02/1999US5977301 Synthesis of N-substituted oligomers
11/02/1999US5977300 Isolated nonapeptide which bind to HLA-B44 molecules and the uses thereof
11/02/1999US5977299 Peptide having terminal activating group; for sensitive diagnostics; therapy
11/02/1999US5977296 Chiral peptide nucleic acid monomers and oligomers
11/02/1999US5977178 Compounds with growth hormone releasing properties
11/02/1999US5977160 Methods for reducing risk of repeat myocardial infarction and increasing survival in heart attack victims
11/02/1999US5977159 Medical use of an ace-inhibitor for treatment of dyspeptic symptoms
11/02/1999US5977137 Sulfonamide inhibitors of aspartyl protease
11/02/1999US5977085 Vectors carrying coding sequence for the SpsB protein of Staphylococcus aureus
11/02/1999US5977084 Self-assembling polynucleotide delivery method
11/02/1999US5977083 Vascular disorders; kidney disorders; hypotensive agents
11/02/1999US5977080 Sulfated disaccharide inhibitors of selectins, methods for synthesis and therapeutic use
11/02/1999US5977076 Carrier coupled to dipetide; antiinflammatory agents; grafting tissue
11/02/1999US5977075 N-aroylamino acid amides as endothelin inhibitors
1 ... 2460 2461 2462 2463 2464 2465 2466 2467 2468 2469 2470 2471 2472 2473 2474 2475 2476 2477 2478 2479 2480 ... 3163